|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| A01K 67/0271 | (2013.01) | ||
| C07K 14/535 | (2006.01) | ||
| A01K 67/0276 | (2013.01) | ||
| C07K 14/715 | (2006.01) | ||
| A01K 67/0278 | (2013.01) | ||
| C07K 14/54 | (2006.01) | ||
| A61K 49/0008 | (2013.01) | ||
| C07K 14/52 | (2006.01) | ||
| C07K 14/505 | (2013.01) | ||
| C07K 14/505 | (2006.01) | ||
| C07K 14/524 | (2013.01) | ||
| C07K 14/535 | (2013.01) | ||
| C12N 9/00 | (2006.01) | ||
| A61K 49/00 | (2006.01) | ||
| C07K 14/5437 | (2013.01) | ||
| G01N 33/50 | (2006.01) | ||
| C07K 14/7155 | (2013.01) | ||
| C07K 14/47 | (2006.01) | ||
| C07K 14/4703 | (2013.01) | ||
| C12N 9/14 | (2006.01) | ||
| C12N 9/00 | (2013.01) | ||
| G01N 33/5088 | (2013.01) | ||
| C12Q 1/18 | (2006.01) | ||
| A01K2207/12 | (2013.01) | ||
| A01K2207/15 | (2013.01) | ||
| A01K2217/072 | (2013.01) | ||
| A01K2217/075 | (2013.01) | ||
| A01K2217/15 | (2013.01) | ||
| A01K2227/105 | (2013.01) | ||
| A01K2267/0337 | (2013.01) | ||
| A01K2267/0381 | (2013.01) | ||
| C12Q 1/18 | (2013.01) | ||
| C12N 9/14 | (2013.01) | ||
| C12Y 301/03048 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 3841877 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20209073.4 |
| Europos patento paraiškos padavimo data | 2015-05-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-06-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201462000460 P | 2014-05-19 | US |
| (72) |
MURPHY, Andrew J. , US
STEVENS, Sean , US
FLAVELL, Richard , US
MANZ, Markus , CH
SHAN, Liang , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
Yale University , Two Whitney Avenue, New Haven, CT 06510, US Institute for Research in Biomedicine (IRB) , Via Francesco Chiesa 5, 6500 Bellinzona, CH |
| (54) | GENETICALLY MODIFIED MICE EXPRESSING HUMAN EPO |
| GENETICALLY MODIFIED MICE EXPRESSING HUMAN EPO |